Pomaglumetad methionil

Modify Date: 2024-01-02 14:10:15

Pomaglumetad methionil Structure
Pomaglumetad methionil structure
Common Name Pomaglumetad methionil
CAS Number 956385-05-0 Molecular Weight 384.42600
Density N/A Boiling Point N/A
Molecular Formula C12H20N2O8S2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Pomaglumetad methionil


Pomaglumetad methionil (LY2140023 hydrate) is an oral methionine prodrug of the potent specific mGlu2/3 receptor agonist LY404039 (HY-50906). Pomaglumetad methionil is well-tolerated and has a distinct safety profile, and can be used to treat schizophrenia[1][2].

 Names

Name (1R,4S,5S,6S)-4-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-2,2-dioxo-2λ6-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid,hydrate
Synonym More Synonyms

 Pomaglumetad methionil Biological Activity

Description Pomaglumetad methionil (LY2140023 hydrate) is an oral methionine prodrug of the potent specific mGlu2/3 receptor agonist LY404039 (HY-50906). Pomaglumetad methionil is well-tolerated and has a distinct safety profile, and can be used to treat schizophrenia[1][2].
Related Catalog
Target

mGlu2/3 receptor[1][2]

References

[1]. Adams DH, et al. A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia. BMC Psychiatry. 2013 May 22;13:143.

[2]. Downing AM, et al. A Double-Blind, Placebo-Controlled Comparator Study of LY2140023 monohydrate in patients with schizophrenia. BMC Psychiatry. 2014 Dec 10;14:351.

 Chemical & Physical Properties

Molecular Formula C12H20N2O8S2
Molecular Weight 384.42600
Exact Mass 384.06600
PSA 210.26000
LogP 0.69110

 Synonyms

Pomaglumetad methionil
UNII-WE665JB15R